-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TQGMtAGNFZUfhD1oDpHtc9m8kv/h31cl430NkvPrvZcmoXi9olC1zB6uaRkWRGly SMg1S0+ZIE3uzqrp8RMB5Q== 0001317757-09-000021.txt : 20091202 0001317757-09-000021.hdr.sgml : 20091202 20091202160414 ACCESSION NUMBER: 0001317757-09-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091201 FILED AS OF DATE: 20091202 DATE AS OF CHANGE: 20091202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Healey Timothy G CENTRAL INDEX KEY: 0001382032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 091217685 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS, INC. STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-12-01 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001382032 Healey Timothy G C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 SVP-Commercial Operations Common Stock 2009-12-01 4 M 0 750 A 750 D Common Stock 2009-12-01 4 S 0 750 37.47 D 0 D Restricted Stock Unit 0 2009-12-01 4 M 0 750 0 D Common Stock 750 750 D The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below. Not applicable. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person. This restricted stock unit grant vests in four equal installments. The first installment vested on December 1, 2007. The second installment vested on December 1, 2008 and the third installment vested on December 1, 2009. The remaining installment will vest on December 1, 2010. Joseph L. Farmer, attorney-in-fact 2009-12-02 -----END PRIVACY-ENHANCED MESSAGE-----